Similar Items: PSMA‐Targeting Macrophage Membrane‐Coated Nanoparticles for Precision Diagnosis and Combination Therapy of Prostate Cancer
- Fractionation gives therapeutic benefit in animal model of [Lu]Lu-PSMA-617 therapy of prostate cancer
- Cell membrane‐coated nanoparticles for dermatological diseases
- Surface-Modified Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a New Perspective for Prostate Cancer Therapy
- Comparative evaluation of [¹⁸F]FAPI-42 and [¹⁸F]PSMA-1007 PET/CT for lesion detection and uptake in prostate cancer across disease stages
- Development of niosomal nanoparticles loaded with cisplatin and vorinostat combination for cancer therapy
- Dual-targeted approaches in cancer therapy: integrating siRNA and chemotherapy for improved outcomes